Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Author(s) -
Patricia Muñóz,
Emilio Bouza,
M. Cuenca-Estrella,
José Marı́a Eiros Bouza,
María Jesús Pérez-Granda,
M. Sánchez-Somolinos,
C. Rincon,
Javier Hortal,
Teresa Peláez
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/429916
Subject(s) - medicine , fungemia , probiotic , saccharomyces boulardii , discontinuation , intensive care unit , clostridium difficile , outbreak , diarrhea , surgery , microbiology and biotechnology , antibiotics , virology , biology , mycosis , bacteria , genetics
Saccharomyces cerevisiae is well known in the baking and brewing industry and is also used as a probiotic in humans. However, it is a very uncommon cause of infection in humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom